We have carried out a quantitative analysis of ER-alpha and ER-beta mRNA expression in normal (n = 11) and breast cancer (n = 112) tissues using a real-time (Taq-Man) PCR assay. Expression of ER-beta mRNA variants has also been studied by triple-primer PCR assay. ER-alpha mRNA levels in normal breas
Quantitation of Estrogen Receptor mRNA Copy Numbers in Breast Cancer Cell Lines and Tumors
✍ Scribed by Indra Poola; Donna M. Williams; Sailaja Koduri; Jayanthi Ramprakash; Robert E. Taylor; W.David Hankins
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 196 KB
- Volume
- 258
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The prognosis for patients with estrogen receptor (ER)‐positive breast cancer has improved significantly with the prescription of selective ER modulators (SERMs) for ER‐positive breast cancer treatment. However, only a proportion of ER‐positive tumors respond to SERMs, and resistance to
## Abstract Plant‐derived phytoestrogens and estrogens in hormone replacement therapies have overlapping yet sometimes divergent effects on the incidence of breast cancer and osteoporosis. Using human MCF‐7 breast carcinoma and G‐292 osteosarcoma cell lines, it was investigated whether the phytoest
## Abstract We show that siRNA‐mediated suppression of protein tyrosine phosphatase α (PTPα) reduces Src activity 2 to 4‐fold in breast, colon and other human cancer cell lines. Src and PTPα RNAi induced apoptosis in estrogen receptor (ER)‐negative breast cancer and colon cancer cells, but not in i
## Abstract Normal mammary epithelial cells are rapidly induced to G~1~ arrest by the widely expressed cytokine, transforming growth factor beta (TGF‐β1). Studies in established breast cancer cell lines that express the estrogen receptor alpha (ERα) have demonstrated loss of this responsiveness. Th